scholarly article | Q13442814 |
P50 | author | Hans-Dieter Volk | Q84015469 |
Richard M Ransohoff | Q87833085 | ||
Tjalf Ziemssen | Q39885017 | ||
Christopher Linington | Q41652456 | ||
Thomas Ritter | Q43123409 | ||
Monika Bradl | Q48527075 | ||
P2093 | author name string | Hans Lassmann | |
Wolfgang E F Klinkert | |||
Alexander Flügel | |||
Silke Lassmann | |||
Zhaoxia Li | |||
Hartmut Wekerle | |||
Naoto Kawakami | |||
Francesca Odoardi | |||
Joachim W Ellwart | |||
Kimberly Krivacic | |||
P2860 | cites work | The immunological synapse: a molecular machine controlling T cell activation | Q28139151 |
Single cell analysis reveals regulated hierarchical T cell antigen receptor signaling thresholds and intraclonal heterogeneity for individual cytokine responses of CD4+ T cells | Q28755947 | ||
Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis | Q28755978 | ||
Improved retroviral vectors for gene transfer and expression | Q29614384 | ||
In situ hybridization analysis of glial fibrillary acidic protein mRNA reveals evidence of biphasic astrocyte activation during acute experimental autoimmune encephalomyelitis | Q30445028 | ||
Innate and adaptive immune responses can be beneficial for CNS repair | Q33659759 | ||
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines | Q33699380 | ||
Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes | Q33846443 | ||
Butyrophilin, a milk protein, modulates the encephalitogenic T cell response to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis. | Q33914297 | ||
Antigen challenge leads to in vivo activation and elimination of highly polarized TH1 memory T cells | Q34028445 | ||
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis | Q34398673 | ||
Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent. | Q34469829 | ||
Thymic expression of the golli-myelin basic protein gene in the SJL/J mouse | Q71686658 | ||
An immunocytochemical study on the localization of S-100 protein in the retina of rats | Q71788991 | ||
An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis | Q71829114 | ||
Thymic expression of myelin basic protein (MBP). Activation of MBP-specific T cells by thymic cells in the absence of exogenous MBP | Q71860113 | ||
Multiple sclerosis. Immunomodulatory effects of human astrocytes on T cells | Q72406707 | ||
Chemokine upregulation follows cytokine expression in chronic relapsing experimental autoimmune encephalomyelitis | Q73579436 | ||
Neuronal FasL induces cell death of encephalitogenic T lymphocytes | Q73967077 | ||
Astrocytes induce hyporesponses of myelin basic protein-reactive T and B cell function | Q77194727 | ||
Targeting monocyte recruitment in CNS autoimmune disease | Q34654762 | ||
Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis | Q35764734 | ||
Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor | Q36099395 | ||
Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. | Q36363728 | ||
In situ tolerance within the central nervous system as a mechanism for preventing autoimmunity | Q36368865 | ||
The distribution of Ia antigen in the lesions of rat acute experimental allergic encephalomyelitis | Q36460010 | ||
A safe packaging line for gene transfer: separating viral genes on two different plasmids | Q36865708 | ||
Checkpoints in the progression of autoimmune disease: lessons from diabetes models | Q37689425 | ||
On the dynamics of TCR:CD3 complex cell surface expression and downmodulation | Q40837872 | ||
Expression of autoimmune disease-related antigens by cells of the immune system | Q41000003 | ||
The thymus and self-tolerance: co-existence of encephalitogenic S100 beta-specific T cells and their nominal autoantigen in the normal adult rat thymus | Q41107539 | ||
Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system | Q41122843 | ||
Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis | Q41433234 | ||
T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. | Q41552341 | ||
Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, S100 beta | Q41573821 | ||
Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages | Q42017099 | ||
Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. | Q42754846 | ||
Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis | Q43477225 | ||
Apoptosis in the nervous system in experimental allergic encephalomyelitis | Q44335881 | ||
Myelin basic proteins | Q46499798 | ||
The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis | Q46865215 | ||
Selective chemokine mRNA accumulation in the rat spinal cord after contusion injury | Q47711401 | ||
Prevention of experimental autoimmune encephalomyelitis by MIP-1alpha and MCP-1 naked DNA vaccines | Q48140731 | ||
Gene transfer into CD4+ T lymphocytes: green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses | Q48170011 | ||
Cytokine regulation of CC and CXC chemokine expression by human astrocytes | Q48246768 | ||
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology | Q48357515 | ||
Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration | Q48463886 | ||
Cytokine induction of MIP-1 alpha and MIP-1 beta in human fetal microglia | Q48479001 | ||
Myelin basic protein-related proteins in mouse brain and immune tissues | Q48568566 | ||
The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis | Q53438445 | ||
Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice | Q57042734 | ||
Detection by S-100 immunolabelling of interdigitating reticulum cells in human thymomas | Q57706899 | ||
Migratory Activity and Functional Changes of Green Fluorescent Effector Cells before and during Experimental Autoimmune Encephalomyelitis | Q61709677 | ||
The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat | Q61709774 | ||
Animal models | Q61709827 | ||
An immunohistochemical study of thymic epithelial tumors. III. The distribution of interdigitating reticulum cells and S-100 beta-positive small lymphocytes | Q68621838 | ||
Limiting dilution analysis of the frequency of antigen-reactive lymphocytes isolated from the central nervous system of Lewis rats with experimental allergic encephalomyelitis | Q68998856 | ||
T-lymphocyte entry into the central nervous system | Q70156307 | ||
Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury to the brain | Q71151706 | ||
T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis | Q71611171 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 185-197 | |
P577 | publication date | 2004-01-01 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis | |
P478 | volume | 199 |
Q30536629 | 2-photon imaging of phagocyte-mediated T cell activation in the CNS. |
Q51035236 | A combination of fluorescent NFAT and H2B sensors uncovers dynamics of T cell activation in real time during CNS autoimmunity. |
Q43002173 | A mighty mouse: building a better model of multiple sclerosis |
Q35868821 | A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE. |
Q36438067 | AKAP9 regulates activation-induced retention of T lymphocytes at sites of inflammation |
Q47300929 | ATG-dependent phagocytosis in dendritic cells drives myelin-specific CD4+ T cell pathogenicity during CNS inflammation |
Q48175463 | Active induction of experimental allergic encephalomyelitis |
Q38020962 | An autoimmunity odyssey: how autoreactive T cells infiltrate into the CNS. |
Q36742838 | Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease. |
Q33620003 | Autoimmune T cell responses in the central nervous system |
Q30480854 | Blood-borne soluble protein antigen intensifies T cell activation in autoimmune CNS lesions and exacerbates clinical disease |
Q28510098 | CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis |
Q53015646 | CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. |
Q37990784 | CXCL12 in control of neuroinflammation. |
Q33756218 | Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. |
Q41649247 | Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice. |
Q59070288 | Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions |
Q40008069 | Effector T-cell trafficking between the leptomeninges and the cerebrospinal fluid |
Q35498194 | Effects of exercise in experimental autoimmune encephalomyelitis (an animal model of multiple sclerosis). |
Q37330915 | Emotional change-associated T cell mobilization at the early stage of a mouse model of multiple sclerosis |
Q37059149 | Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin. |
Q34126511 | FLT-3 expression and function on microglia in multiple sclerosis |
Q35162073 | Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity |
Q33661625 | Gender and uveitis in patients with multiple sclerosis |
Q36303835 | Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS. |
Q34650883 | Immunoadsorption patients with multiple sclerosis: an open-label pilot study |
Q48416754 | Immunology: In the beginning |
Q37184161 | Inflammation on the mind: visualizing immunity in the central nervous system. |
Q30478895 | Instant effect of soluble antigen on effector T cells in peripheral immune organs during immunotherapy of autoimmune encephalomyelitis |
Q84523729 | Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice |
Q33630513 | Knocking at the brain's door: intravital two-photon imaging of autoreactive T cell interactions with CNS structures |
Q36403771 | Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. |
Q30510541 | Localizing central nervous system immune surveillance: meningeal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis |
Q59129045 | Loss of HDAC11 ameliorates clinical symptoms in a multiple sclerosis mouse model |
Q36636588 | MHC class I-restricted myelin epitopes are cross-presented by Tip-DCs that promote determinant spreading to CD8⁺ T cells |
Q49713173 | Mechanisms for lesion localization in neuromyelitis optica spectrum disorders. |
Q35102242 | Migration of cytotoxic lymphocytes in cell cycle permits local MHC I-dependent control of division at sites of viral infection |
Q35052673 | Molecular control of physiological and pathological T-cell recruitment after mouse spinal cord injury |
Q36642040 | Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease |
Q27023735 | Multiple sclerosis: molecular mechanisms and therapeutic opportunities |
Q38700383 | Natural Docosahexaenoic Acid in the Triglyceride Form Attenuates In Vitro Microglial Activation and Ameliorates Autoimmune Encephalomyelitis in Mice. |
Q31044261 | Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE). |
Q34924709 | Neutrophil-related factors as biomarkers in EAE and MS. |
Q36991434 | New insights into adaptive immunity in chronic neuroinflammation |
Q30495158 | Nicotinic acid adenine dinucleotide phosphate-mediated calcium signalling in effector T cells regulates autoimmunity of the central nervous system. |
Q37075692 | Notch signaling regulates T cell accumulation and function in the central nervous system during experimental autoimmune encephalomyelitis. |
Q39563633 | Pathogenic T cell responses against aquaporin 4. |
Q94560740 | Perivascular Unit: This Must Be the Place. The Anatomical Crossroad Between the Immune, Vascular and Nervous System |
Q82644053 | Regulatory T cells fail to suppress CD4T+-bet+ T cells in relapsing multiple sclerosis patients |
Q30574747 | Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells |
Q26795528 | Role of T cell-glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptoms |
Q40189763 | Sex Bias in Pathogenesis of Autoimmune Neuroinflammation: Relevance for Dimethyl Fumarate Immunomodulatory/Anti-oxidant Action |
Q36999743 | Sex and gender issues in multiple sclerosis |
Q33880465 | Site-specific chemokine expression regulates central nervous system inflammation and determines clinical phenotype in autoimmune encephalomyelitis |
Q35570382 | Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis |
Q37680135 | Swift entry of myelin-specific T lymphocytes into the central nervous system in spontaneous autoimmune encephalomyelitis |
Q39039987 | T cell-activation in neuromyelitis optica lesions plays a role in their formation. |
Q48401917 | T cells become licensed in the lung to enter the central nervous system |
Q37754572 | T-cell response dynamics in animal models of multiple sclerosis: implications for immunotherapies |
Q90050404 | The Role of the CXCL12/CXCR4/ACKR3 Axis in Autoimmune Diseases |
Q38035711 | The anatomical and cellular basis of immune surveillance in the central nervous system. |
Q33595360 | The chemokine receptor antagonist, TAK-779, decreased experimental autoimmune encephalomyelitis by reducing inflammatory cell migration into the central nervous system, without affecting T cell function |
Q85174183 | The clinical course of EAE is reflected by the dynamics of the neuroantigen-specific T cell compartment in the blood |
Q35155753 | The double-edged sword of autoimmunity: lessons from multiple sclerosis |
Q39090554 | The movers and shapers in immune privilege of the CNS. |
Q34024675 | The myeloid cells of the central nervous system parenchyma |
Q28265780 | The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination |
Q28071461 | Vascular, glial, and lymphatic immune gateways of the central nervous system |
Q41292936 | Visualizing context-dependent calcium signaling in encephalitogenic T cells in vivo by two-photon microscopy |
Search more.